A leading provider of
innovative DNA Screening solutions
FGFR1 Breakapart/Amplification LPS 018
Fibroblast Growth Factor Receptor 1 (FGFR1), located on chromosome 8, was the first gene to be shown to become amplified in some breast cancers and has also been found to be translocated in patients with 8p11 myeloproliferative syndrome.
Amplification of the gene is thought to be the causative factor in around 10% of breast tumours and has been shown to provide a poor prognosis to patients because over-expression of the gene product can lead to early relapse.
FGFR1 Breakapart/Amplification
Cat. No. LPS 018-S (5 tests)
Cat. No. LPS 018 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK